C4 Therapeutics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

c4therapeutics.com

C4 Therapeutics has not claimed their Profile.

2 of C4 Therapeutics's Competitors have claimed theirs.

Here's what their competitors are saying:

FIMECS company logo

FIMECS claims to be a better solution than C4 Therapeutics due to:

Drug discovery strategy for TPD, new modality are different. RaPPIDS is enable to synthesize and evaluate a large number of divergent compounds. Therefore, we can make a decision by actual data of the compounds although competitor is aiming for efficiency based on computational chemistry. In addition, FIMECS has an ingenious phenotype-first E3 binder identification scheme and has proprietary orally available E3 binders. Finally, RaPPIDS-based research cost can be significantly decreased by automated synthetic manner.

Pin Therapeutics company logo

Pin Therapeutics claims to be a better solution than C4 Therapeutics due to:

having a molecular glue platform and several molecular glue degrader pipelines.

C4 Therapeutics's alternatives and competitors

See how C4 Therapeutics compares to similar products. C4 Therapeutics's top competitors include Pin Therapeutics, and FIMECS.

PT
Analyst Briefing Submitted

Pin Therapeutics is a pharmaceutical company that creates therapeutic products based on chemical biology-driven protein degradation, including PROTAC technology. The co…

C4 Therapeutics vs. Pin Therapeutics

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • FI
    Analyst Briefing Submitted

    FIMECS is a drug discovery biotech firm focused on developing protein degradation therapeutics for cancers and other difficult-to-treat diseases.

    C4 Therapeutics vs. FIMECS

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

Top 2 C4 Therapeutics competitors

Work for C4 Therapeutics?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

Amphista Therapeutics Logo
Amphista Therapeutics

Amphista Therapeutics is a biopharmaceutical company that creates cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease-causing proteins.

P
Pin Therapeutics

Pin Therapeutics is a pharmaceutical company that creates therapeutic products based on chemical biology-driven protein degradation, including PROTAC technology. The company aims to develop PROTAC compounds for oncology, neurodegenerative diseases, and cardiovascular indications based on disease-agnostic approaches.

F
FIMECS

FIMECS is a drug discovery biotech firm focused on developing protein degradation therapeutics for cancers and other difficult-to-treat diseases.

Arvinas Logo
Arvinas

Arvinas (NASDAQ: ARVN) is a pharmaceutical company focused on developing small molecules aimed at degrading disease-causing cellular proteins. The company is translating these protein degradation approaches into drugs for the treatment of cancer and other diseases. Many diseases are a result of "rogue," uncontrolled proteins, whose absence could bring great clinical benefit to patients.

Kymera Therapeutics Logo
Kymera Therapeutics

Kymera Therapeutics (NASDAQ: KYMR) is a biotechnology company that develops an approach to treating previously untreatable diseases. Kymera aims to accelerate drug discovery with an ability to target and degrade proteins and advance treatment options for patients.

Nurix Therapeutics Logo
Nurix Therapeutics

Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. The drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.